Salud financiera de hoja de balance de Bora Pharmaceuticals
Salud financiera controles de criterios 3/6
Bora Pharmaceuticals tiene un patrimonio de accionistas total de NT$13.9B y una deuda total de NT$17.9B, lo que sitúa su ratio deuda-patrimonio en 128.3%. Sus activos y pasivos totales son NT$43.6B y NT$29.6B respectivamente. El BAIT de Bora Pharmaceuticals es de NT$4.0B, por lo que su ratio de cobertura de intereses es de 10.5. Tiene efectivo e inversiones a corto plazo que ascienden a NT$6.5B.
Información clave
128.3%
Ratio deuda-patrimonio
NT$17.87b
Deuda
| Ratio de cobertura de intereses | 10.5x |
| Efectivo | NT$6.51b |
| Patrimonio | NT$13.93b |
| Total pasivo | NT$29.64b |
| Activos totales | NT$43.57b |
Actualizaciones recientes sobre salud financiera
Bora Pharmaceuticals (TWSE:6472) Could Easily Take On More Debt
Apr 08
Is Bora Pharmaceuticals (GTSM:6472) A Risky Investment?
Apr 30Bora Pharmaceuticals (GTSM:6472) Takes On Some Risk With Its Use Of Debt
Jan 19Recent updates
Bora Pharmaceuticals' (TWSE:6472) Earnings Are Weaker Than They Seem
Nov 21Does Bora Pharmaceuticals (TWSE:6472) Deserve A Spot On Your Watchlist?
Oct 04Investors Appear Satisfied With Bora Pharmaceuticals Co., LTD.'s (TWSE:6472) Prospects
Jul 18Is Bora Pharmaceuticals Co., LTD. (TWSE:6472) Trading At A 44% Discount?
Jun 13Bora Pharmaceuticals Co., LTD. (TWSE:6472) Stock Rockets 33% As Investors Are Less Pessimistic Than Expected
Apr 10Bora Pharmaceuticals (TWSE:6472) Could Easily Take On More Debt
Apr 08Shareholders Can Be Confident That Bora Pharmaceuticals' (TWSE:6472) Earnings Are High Quality
Mar 14Is Bora Pharmaceuticals (GTSM:6472) A Risky Investment?
Apr 30Are Strong Financial Prospects The Force That Is Driving The Momentum In Bora Pharmaceuticals Co., LTD.'s GTSM:6472) Stock?
Mar 17Bora Pharmaceuticals (GTSM:6472) Has Rewarded Shareholders With An Exceptional 695% Total Return On Their Investment
Feb 17
New Forecasts: Here's What Analysts Think The Future Holds For Bora Pharmaceuticals Co., LTD. (GTSM:6472)
Jan 27Bora Pharmaceuticals (GTSM:6472) Takes On Some Risk With Its Use Of Debt
Jan 19We're Not So Sure You Should Rely on Bora Pharmaceuticals's (GTSM:6472) Statutory Earnings
Dec 29Are Robust Financials Driving The Recent Rally In Bora Pharmaceuticals Co., LTD.'s (GTSM:6472) Stock?
Dec 09Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo (NT$23.8B) de 6472 superan a sus pasivos a corto plazo (NT$13.1B).
Pasivo a largo plazo: Los activos a corto plazo de 6472 (NT$23.8B) superan a sus pasivos a largo plazo (NT$16.5B).
Historial y análisis de deuda-patrimonio
Nivel de deuda: La relación deuda neta-capital de 6472 (81.6%) se considera alta.
Reducción de la deuda: El ratio deuda-patrimonio de 6472 ha crecido de 32% a 128.3% en los últimos 5 años.
Cobertura de la deuda: La deuda de 6472 no está bien cubierta por el flujo de caja operativo (13.2%).
Cobertura de intereses: Los pagos de intereses de la deuda de 6472 están bien cubiertos por el BAIT (10.5x cobertura).